These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn. Kandulski A, Jechorek D, Caro C, Weigt J, Wex T, Mönkemüller K, Malfertheiner P. Aliment Pharmacol Ther; 2013 Sep 22; 38(6):643-51. PubMed ID: 23895770 [Abstract] [Full Text] [Related]
23. Journal of Pediatric Gastroenterology and Nutrition. Introduction. Illueca M. J Pediatr Gastroenterol Nutr; 2015 Jul 22; 60 Suppl 1():S1. PubMed ID: 26121344 [No Abstract] [Full Text] [Related]
24. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease? Vakil N. Aliment Pharmacol Ther; 2005 Aug 22; 22 Suppl 1():64-9. PubMed ID: 16042661 [Abstract] [Full Text] [Related]
25. When asking the right question, conventional pH-monitoring provides the right answer. Tutuian R. J Gastrointestin Liver Dis; 2009 Mar 22; 18(1):9-10. PubMed ID: 19337626 [No Abstract] [Full Text] [Related]
26. The proton pump inhibitor test for gastroesophageal reflux disease: optimal cut-off value and duration. de Leone A, Tonini M, Dominici P, Grossi E, Pace F, EMERGE Study Group. Dig Liver Dis; 2010 Nov 22; 42(11):785-90. PubMed ID: 20452300 [Abstract] [Full Text] [Related]
27. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Dent J, Vakil N, Jones R, Bytzer P, Schöning U, Halling K, Junghard O, Lind T. Gut; 2010 Jun 22; 59(6):714-21. PubMed ID: 20551454 [Abstract] [Full Text] [Related]
28. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association. Aanen MC, Weusten BL, Numans ME, de Wit NJ, Samsom M, Smout AJ. J Clin Gastroenterol; 2008 Jun 22; 42(5):441-7. PubMed ID: 18344896 [Abstract] [Full Text] [Related]
29. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study. Bretagne JF, Rey JF, Caekaert A, Barthélemy P. Dig Liver Dis; 2005 Aug 22; 37(8):566-70. PubMed ID: 15886080 [Abstract] [Full Text] [Related]
30. Author's reply to "comment on: predictors of clinical response of acid suppression in Chinese patients with gastrooesophageal reflux disease". Wang AJ, Wang H, Zhu X. Dig Liver Dis; 2013 Oct 22; 45(10):869-70. PubMed ID: 23664269 [No Abstract] [Full Text] [Related]
31. Chronic cough in Swiss bagpipe player. Schindler V, Gubler C, Turk A, Becker AS, Pohl D. Gut; 2018 Oct 22; 67(10):1792. PubMed ID: 29247067 [No Abstract] [Full Text] [Related]
32. Heartburn and gastro-oesophageal reflux. Bennett JR. Br J Clin Pract; 1991 Oct 22; 45(4):273-7. PubMed ID: 1810362 [Abstract] [Full Text] [Related]
33. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Zerbib F, Duriez A, Roman S, Capdepont M, Mion F. Gut; 2008 Feb 22; 57(2):156-60. PubMed ID: 17951358 [Abstract] [Full Text] [Related]
34. Correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease. Sarnelli G, De Giorgi F, Efficie E, Aprea G, Masone S, Savarese MF, Esposito I, Russo L, Cuomo R. Eur J Gastroenterol Hepatol; 2008 Apr 22; 20(4):264-8. PubMed ID: 18334868 [Abstract] [Full Text] [Related]
36. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients. Davidson G, Wenzl TG, Thomson M, Omari T, Barker P, Lundborg P, Illueca M. J Pediatr; 2013 Sep 22; 163(3):692-8.e1-2. PubMed ID: 23800403 [Abstract] [Full Text] [Related]
37. Symptom predictability in gastroesophageal reflux disease and role of proton pump inhibitor test. Estores DS. Gastroenterol Clin North Am; 2014 Mar 22; 43(1):27-38. PubMed ID: 24503357 [Abstract] [Full Text] [Related]
38. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease. Kahrilas PJ, Hughes N, Howden CW. Gut; 2011 Nov 22; 60(11):1473-8. PubMed ID: 21508423 [Abstract] [Full Text] [Related]
39. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease. Friedlander EA, Pallentino J, Miller SK, VanBeuge SS. J Am Acad Nurse Pract; 2010 Dec 22; 22(12):674-83. PubMed ID: 21129076 [Abstract] [Full Text] [Related]
40. 24-hour ambulatory pH-metry in patients with refractory heartburn: a prospective study. Talaie R, Forootan M, Donboli K, Dadashzadeh N, Sadeghi A, Poorsaadat S, Moghimi B, Mohammad Alizadeh AH, Zali MR. J Gastrointestin Liver Dis; 2009 Mar 22; 18(1):11-5. PubMed ID: 19337627 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]